Thieme E-Books & E-Journals - Zeitschrift für Gastroenterologie / Issue

P1_01

Alexi, P; Weiskirchen, R: Modulation of intracellular TGF-beta signalling by different PDGF isoforms and MEK1/2 in a murine hepatic stellate cell line

Abstract
HTML

P1_02

Altomonte, J; Hellerbrand, C; Ebert, O: Antifibrotic properties of transarterial VSV oncolytic therapy for hepatocellular carcinoma in rats with TAA-induced liver fibrosis

Abstract
HTML

P1_03

Amanzada, A; Malik, IA; Sultan, S; Ramadori, G: Gesteigerte Myeloperoxidase-Genexpression durch Zunahme der Neutrophilen-Granulozytenpopulation bei akuter Leberschädigung

Abstract
HTML

P1_04

Arndt, S; Wacker, E; Mägdefrau, U; Dorn, C; Hellerbrand, C; Bosserhoff, A: BMP6 protects against hepatic fibrosis in experimental NASH models

Abstract
HTML

P1_05

Barikbin, R; Schwinge, D; Schramm, C; Tiegs, G; Sass, G: Induction of HEME Oxygenase 1 reduces inflammation and fibrosis in a mouse model of chronic hepatitis

Abstract
HTML

P1_06

Bohr, W; Lux, S; Borkham-Kamphorst, E; Van de Leur, E; Kupper, M; Hoffmann, K; Weiskirchen, R: Recombinant expression, purification and functional impact of CTGF/CCN2 and NOV/CCN3 on liver fibrogenesis

Abstract
HTML

P1_07

Breitkopf-Heinlein, K; Gaitantzi, H; Li, Q; Mueller, A; Dooley, S: In the presence of ethanol TGF-β effects switch from pro-survival to apoptotic in hepatocytes

Abstract
HTML

P1_08

Buechler, C; Wiest, R; Bauer, S; Wanninger, J; Neumeier, M; Farkas, S; Scherer, M; Schaeffler, A: Impaired hepatic removal of galectin–3 and association with worse liver function in patients with alcoholic liver cirrhosis

Abstract
HTML

P1_09

Churin, Y; Roderfeld, M; Glebe, D; Roeb, E: Mouse model for HBV-associated liver fibrosis

Abstract
HTML

P1_10

Czech, B; Stevens, A; Kirovski, G; Saugspier, M; Dorn, C; Valletta, D; Bosserhoff, A; Oefner, P; Hellerbrand, C: Expression and function of methylthioadenosine phosphorylase (MTAP) in chronic liver disease

Abstract
HTML

P1_11

Dayoub, R; Rebs, S; Schlitt, HJ; Melter, M; Weiss, TS: Hepatic lipotoxicity and Fibrogenesis are attenuated by the hepatotrophic factor ALR

Abstract
HTML

P1_12

Dayoub, R; Lamlé, J; Vogel, A; Werner, S; Schlitt, HJ; Melter, M; Weiss, TS: Nrf2, a transcription factor mainly involved in antioxidant defense, regulates the expression of ALR, Augmenter of Liver Regeneration

Abstract
HTML

P1_13

Dorn, C; Gäbele, E; Schardt, K; Büttner, R; Hellerbrand, C: Interstrain differences in susceptibility to non-alcoholic steatohepatitis

Abstract
HTML

P1_14

Dorn, C; Hellerbrand, C: Aging promotes susceptibility to non-alcoholic steatohepatitis in mice

Abstract
HTML

P1_15

Dorn, C; Blank, C; Hellerbrand, C: PD1 expression inhibits hepoatic inflammation and fibrosis in non-alcoholic steatohepatitis

Abstract
HTML

P1_16

Dostert, K; Hellerbrand, C; Gäbele, E: Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates hepatic inflammation and fibrosis in experimental NASH but protects against bile duct ligation induced liver fibrosis

Abstract
HTML

P1_17

Esser, M; Weiskirchen, R; Meurer, SK: Molecular details on BMP-7 activity on TGF-beta1-mediated CTGF expression in myofibroblasts

Abstract
HTML

P1_18

Fund, N; Hall, R; Dooley, S; Lammert, F; Müllenbach, R: Fibrogenic genotype-phenotype correlations in selected BXD recombinant inbred mouse lines: Closer to life?!

Abstract
HTML

P1_19

Gäbele, E; Dostert, K; Dorn, C; Stickel, F; Hellerbrand, C: Alcohol and a high-fat diet synergistically induce hepatic inflammation and fibrosis via TLR4

Abstract
HTML

P1_20

Giebeler, A; Brandenburg, LO; Kaldenbach, M; Birchmeier, C; Trautwein, C; Streetz, K: Die hepatische antibakterielle Antwort nach cholestatischer Leberschädigung ist durch gp130 und c-Met-abhängige Mechanismen reguliert

Abstract
HTML

P1_21

Granzow, M; Klein, S; Gautsch, S; Himmit, M; Linhart, M; Werner, N; Sauerbruch, T; Trebicka, J: Die Rolle des AT1-Rezeptors in der Fibroseentwicklung

Abstract
HTML

P1_22

Hall, RA; Hochrath, K; Lammert, F; Grünhage, F: Identification of interacting modifier loci of liver fibrosis in Abcb4/Mdr2 deficient mice

Abstract
HTML

P1_23

Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F; Grünhage, F: Serum 25-hydroxy-vitamin D3 in chronic liver disease: a transient elastography- based study

Abstract
HTML

P1_24

Kirovski, G; Dorn, C; Huber, H; Moleda, L; Beer, C; Wobser, H; Schacherer, D; Buechler, C; Gäbele, E; Hellerbrand, C: Elevated systemic monocyte chemoattractrant protein-1 levels in hepatic steatosis without significant hepatic inflammation

Abstract
HTML

P1_25

Klein, S; Granzow, M; Gautsch, S; Sauerbruch, T; Trebicka, J: Spontaner portaler Hypertonus bei transgenen mREN2-Ratten

Abstract
HTML

P1_26

Koehl, G; Dostert, K; Dorn, C; Wiest, R; Geissler, E; Hellerbrand, C; Gäbele, E: Rapamycin aggravates experimental non alcoholic steatohepatitis in mice

Abstract
HTML

P1_27

Kwiecinski, M; Elfimova, N; Noetel, A; Töx, U; Strack, I; Steffen, M; Dienes, HP; Odenthal, M: New targets of miR-29 in cell communication during liver fibrogenesis

Abstract
HTML

P1_28

Kwiecinski, M; Elfimova, N; Noetel, A; Schievenbusch, S; Dienes, HP; Odenthal, M: Hepatocyte growth factor (HGF) acts as an antifibrotic mediator by prominent miRNA-29 induction

Abstract
HTML

P1_29

Liu, Y; Meyer, C; Mueller, A; Herweck, F; Li, Q; Muellenbach, R; Mertens, PR; Dooley, S; Weng, H: IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF- independent Smad signaling

Abstract
HTML

P1_30

Lornejad-Schäfer, MR; Schröder, KR; Schäfer, C: Cell viability and hepatocyte-typic functions in co-cultures of proliferating and differentiated HepaRG with LX-2 cells

Abstract
HTML

P1_31

Mahli, A; Dostert, K; Weiss, T; Thasler, W; Gäbele, E; Hellerbrand, C: A novel in vitro model of alcohol-induced hepatic fibrogenesis

Abstract
HTML

P1_32

Malik, IA; Triebel, J; Posselt, J; Raddatz, D; Ramadori, G: Detection of Melanocortin 4 Receptor in rat liver and its regulation during acute phase response

Abstract
HTML

P1_33

Marquardt, JU; Uchida, K; Gillen, MC; Seo, D; Kaposi-Novak, P; Conner, EA; Factor, VM; Thorgeirsson, SS: HGF/c-Met signaling in hepatocytes protects against progression of chronic liver fibrosis

Abstract
HTML

P1_34

Meurer, SK; Tihaa, L; Weiskirchen, R: Expression and function of S-endoglin, a rat specific splice variant of endoglin, in liver cells

Abstract
HTML

P1_35

Meyer, C; Liu, Y; Dzieran, J; Dooley, S: Caveolin-1 is a critical regulator of TGF-β mediated hepatocyte apoptosis

Abstract
HTML

P1_36

Neumann, C; Roderfeld, M; Tschuschner, A; Weiß, M; Roeb, E: Pathologische Rolle von Fibrozyten in murinen Fibrose Modellen (sklerosierende Cholangitis, HBV, CCl4, TAA)

Abstract
HTML

P1_37

Noetel, A; Strack, I; Elfimova, N; Kwiecinski, M; Dienes, HP; Odenthal, M: The pluripotency factor LIN28 is targeted by neuronal microRNAs participating in myofibroblastic differentiation

Abstract
HTML

P1_38

Pascucci, M; Bianchi, A; Ramadori, P; Sultan, S; Martius, G: Lipocalin-2 gene expression and production in a model of acute phase response reaction

Abstract
HTML

P1_39

Pathil, A; Müller, J; Warth, A; Chamulitrat, W; Stremmel, W: Anti-fibrogene Wirkung des Gallensäure-Phospholipid-Konjugates Ursodeoxycholyl Lysophosphatidylethanolamid durch Inhibition des TGFβ1/Smad-Signalweges

Abstract
HTML

P1_40

Pieper-Fürst, U; Hall, R; Sauerbruch, T; Lammert, F: Expression of the multiligand receptor megalin in liver

Abstract
HTML

P1_41

Quint, K; Stoll, M; Wissniowski, T; Agaimy, A; Stickel, F; Di Fazio, P; Ocker, M: Differential expression of PPARalpha, STAT1 and STAT3 in TAA/EtOH-induced liver fibrosis in cannabinoid recepetor 1 knockout mice

Abstract
HTML

P1_42

Roderburg, C; Urban, GW; Vucur, M; Kreggenwinkel, K; Tacke, F; Trautwein, C; Luedde, T: Identifikation eines miRNA-29 basierten Regulationsmechanismus in der Leberzirrhose

Abstract
HTML

P1_43

Roderfeld, M; Rath, T; Güler, C; Zachoval, R; Roeb, E: YKL-40 differenziert als Serummarker niedrige Fibrosegrade bei HCV Patienten

Abstract
HTML

P1_44

Rüdrich, U; Rothe, M; Kirsch, S; Maasoumy, B; Iken, M; Ott, M; Bock, M: Overexpression of Pitx2 induces morphological changes in Adult Liver Derived Progenitor Cells (ALDPC)

Abstract
HTML

P1_45

Sahin, H; Moreno Zaldivar, M; Schmitz, P; Kießling, F; Trautwein, C; Wasmuth, HE: The chemokine CXCL9 inhibits neoangiogenesis and liver fibrosis in vivo

Abstract
HTML

P1_46

Saugspier, M; Dorn, C; Gehrig, M; Heilmann, J; Hellerbrand, C: Hop bitter acids exhibit anti-fibrogenic effects an hepatic stellate cells in vitro

Abstract
HTML

P1_47

Schattenberg, J; Nagel, M; Longerich, T; Kreft, A; He, YW; Galle, PR; Schirmacher, P; Schuchmann, M: Deletion von c-FLIP in Hepatozyten potenziert die Tetrachlorkohlenstoff (CCl4)-induzierte Leberschädigung und Fibrose

Abstract
HTML

P1_48

Seydel, S; Beilfuss, A; Kahraman, A; Aksoy, K; Gerken, G; Akkiz, H; Canbay, A: Vitamin D ameliorates stress ligand expression elicited by free fatty acids in hepatic stellate cells

Abstract
HTML

P1_49

Singh, A; Cubero, FJ; Borkham-Kamphorst, E; Al-Masaoudi, M; Liedtke, C; Luedde, T; Weiskirchen, R; Heikenwälder,, M; Trautwein, C: TRAIL and TNFR1-dependent pathways and their role for progression of Nemo-dependent hepatitis

Abstract
HTML

P1_50

Solomentsew, J; Sass, G; Tiegs, G: Carbon monoxide protects primary mouse hepatocytes from induced apoptosis by activating the nitric oxide pathway

Abstract
HTML

P1_51

Strnad, P; Kucukoglu, O; Lunova, M; Lienau, TC; Stickel, F; Omary, MB: Non-coding keratin variants associate with fibrosis progression in hemochromatosis patients

Abstract
HTML

P1_52

Tacke, F; Zimmermann, HW; Berres, ML; Trautwein, C; Wasmuth, HE: Serumspiegel der Chemokin-Rezeptor CXCR3 Liganden sind in Patienten mit chronischen Lebererkrankungen erhöht und mit Krankheitsprogression, Leberfunktion und Komplikationen assoziiert

Abstract
HTML

P1_53

Teltschik, Z; Beisner, J; Nuding, S; Stange, E; Hofmann, C; Bevins, C; Schoelmerich, J; Wehkamp, J; Wiest, R: Bacterial translocation is associated with downregulation of Paneth cell antimicrobial peptides in ascitic cirrhotic but not in pre-hepatic portal hypertensive rats

Abstract
HTML

P1_54

Valletta, D; Dorn, C; Saugspier, M; Amann, T; Czech, B; Gäbele, E; Bosserhoff, A; Hellerbrand, C: Expression and function of the atypical cadherin Fat1 in liver fibrosis

Abstract
HTML

P1_55

Vogt, R; Godoy, P; Campos, G; Stöber, R; Hengstler, JG; Schlitt, HJ; Melter, M; Weiss, TS: IL-15 mRNA expression is associated with liver cirrhosis

Abstract
HTML

P1_56

Wanninger, J; Neumeier, M; Bauer, S; Weiss, TS; Hellerbrand, C; Schoelmerich, J; Buechler, C: Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity

Abstract
HTML

P1_57

Weng, H; Radaeva, S; Liu, Y; Li, Q; Shen, H; Muellenbach, R; Huang, T; Zimmer, V; Lammert, F; Chen, J; Dooley, S: IFN-gamma inhibits hepatic progenitor cell activation in chronic liver damage

Abstract
HTML

P1_58

Weng, H; Liu, Y; Ilkavets, I; Shen, H; Zimmer, V; Lammert, F; Mueller, A; Herweck, F; Stump, C; Mertens, PR; Dooley, S: Jagged-1 signalling is required in liver fibrogensis

Abstract
HTML

P1_59

Widera, A; Campos, G; Begher-Tibbe, B; Günther, G; Garcia-Perez, C; Stöber, R; Hengstler, JG; Godoy, P: Epithelial to mesenchymal transition in liver regeneration

Abstract
HTML

P1_60

Wiest, R; Gäbele, E; Schoelmerich, J; Moleda, L; Dorn, C; Capellino, S; Straub, RH; Hellerbrand, C; Buettner, R: Systemic chemical sympathectomy does not alter the long-term course of disease in a murine model of non-alcoholic steatohepatitis

Abstract
HTML

P1_61

Wojtalla, A; Herweck, F; Singer, MV; Zimmer, A; Siegmund, SV: The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes

Abstract
HTML

P1_62

Zahn, A; Beilfuss, A; Cicinnati, V; Gerken, G; Canbay, A: Mycophenolic acid, a possible Inhibitor of re-fibrosis in HCV-positive liver transplanted patients

Abstract
HTML

P1_63

Zimmermann, HW; Seidler, S; Gassler, N; Weiskirchen, R; Trautwein, C; Tacke, F: Interleukin-8 korreliert mit dem Schweregrad der Leberfibrose und –zirrhose und ist insbesondere assoziert mit cholestastischen Leberkrankungen

Abstract
HTML

P1_64

Zipprich, A; Engelhardt, M; Christ, B; Seufferlein, T; Dollinger, M: Neoangiogenesis and nitric oxide is increased in hepatic arteries of decompensated but not compensated CCl4-cirrhotic rats, a process that can be blocked by Sorafenib

Abstract
HTML

V1_01

Dietrich, P; Moleda, L; Schoelmerich, J; Wiest, R: Neuropeptid Y (NPY)-vermittelte Korrektur der verstärkten vaskulären sympathoadrenergen Desensibilisierung des mesenterialen Gefäßbettes bei experimenteller portaler Hypertension

Abstract
HTML

V1_02

Grünhage, F; Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F: Association of common SNPs of genes regulating vitamin D homoeostasis with vitamin D levels and liver fibrosis in a cohort of patients with chronic liver disease

Abstract
HTML

V1_03

Heinrichs, D; Jung, M; Berres, ML; Nellen, A; Schmitz, P; Bucala, R; Trautwein, C; Weber, C; Bernhagen, J; Wasmuth, HE: MIF exerts anti-fibrotic effects in experimental liver fibrosis via CD74

Abstract
HTML

Subscribe to RSS

Zeitschrift für Gastroenterologie